ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,458Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 403

$710K Total Retail Price of All Prescriptions

Rank: 17 out of 403

277 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,515 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
DIOVAN HCT 337 333 1 69
AMLODIPINE BESYLATE 328 289 2 4
ZOLPIDEM TARTRATE 286 264 3 16
METOPROLOL SUCCINATE 258 225 4 11
METFORMIN HCL 254 220 5 8
NEXIUM 243 220 6 18
HYDROCHLOROTHIAZIDE 217 198 7 6
DIOVAN 215 193 8 24
SIMVASTATIN 213 204 9 2
LEVOTHYROXINE SODIUM 206 180 10 3
METOPROLOL TARTRATE 205 174 11 10
CRESTOR 199 179 12 19
FUROSEMIDE 188 175 13 7
OMEPRAZOLE 168 156 14 9
EXFORGE 163 163 15 165
ATORVASTATIN CALCIUM 145 115 16 5
GLIPIZIDE 136 115 17 70
ALLOPURINOL 132 132 18 31
MIRTAZAPINE 129 129 19 38
POTASSIUM CHLORIDE 120 102 20 37
LISINOPRIL 117 109 21 1
MECLIZINE HCL 108 103 22 141
SERTRALINE HCL 103 80 23 20
LIPITOR 103 101 23 53
QUINAPRIL HCL 98 68 25 67
GLIMEPIRIDE 91 91 26 61
LANTUS SOLOSTAR 89 78 27 80
WARFARIN SODIUM 87 79 28 12
ESCITALOPRAM OXALATE 84 78 29 36
DONEPEZIL HCL 82 82 30 23
HYDRALAZINE HCL 79 79 31 115
ALENDRONATE SODIUM 77 77 32 26
ISOSORBIDE MONONITRATE ER 76 76 33 62
TRAMADOL HCL-ACETAMINOPHEN 76 51 33 113
ADVAIR DISKUS 76 52 33 33
TRIAMCINOLONE ACETONIDE 63 61 36 149
PEN NEEDLE 63 51 36 137
PRAVASTATIN SODIUM 63 63 36 14
CELEBREX 60 58 39 87
PAROXETINE HCL 59 58 40 68
NAPROXEN 57 45 41 79
TAMSULOSIN HCL 57 54 41 27
DEXILANT 56 48 43 81
LIDODERM 56 53 43 74
EXFORGE HCT 54 54 45 252
CARVEDILOL 54 54 45 32
BYSTOLIC 54 54 45 94
NIASPAN 52 52 48 142
METFORMIN HCL ER 52 52 48 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.